Literature DB >> 9049571

Control of bias in dietary trial to prevent coronary recurrences: The Lyon Diet Heart Study.

M de Lorgeril1, P Salen, E Caillat-Vallet, M T Hanauer, J C Barthelemy, N Mamelle.   

Abstract

BACKGROUND AND OBJECTIVES: A major limitation of dietary trials is that double blind design is not feasible. These trials are therefore prone to biases. The Lyon diet heart study is a single-blind secondary prevention trial to test the hypothesis that a Mediterranean-type of diet may prevent recurrences after a first myocardial infarction. A surprising 73% reduction of the risk of new major cardiac events was observed in the experimental group. For this reason, it is important to describe the methods used in the trial. We now report our techniques to randomize the patients, to change their diet and to control for possible bias, in particular any investigator or attending physician bias.
DESIGN: In this dietary trial, a specific design was used to recruit and randomize the patients without informing them and their physicians that they were participating in a comparative trial. The attending physician bias was evaluated by studying drug usage and the investigator bias by constructing a questionnaire from which specific scores were used to evaluate (1) how the patients appreciated their participation in the study and (2) whether this participation resulted in significant changes in their way of living.
SUBJECTS: 605 survivors of a first myocardial infarction were randomized into either a control or a Mediterranean group.
RESULTS: The two randomized groups were similar for all the variables of prognosis. Drug usage was not significantly different between groups, suggesting that there was no major attending physician bias. Analyses of the appreciation scores and of the change score did not detect any significant investigator bias.
CONCLUSIONS: Although the study cannot be completely shielded from minor biases, the data presented here provide evidence that the dietary modifications per se were protective, not other (including psychosocial) changes resulting from the participation to the trial.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049571     DOI: 10.1038/sj.ejcn.1600374

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  15 in total

1.  Why heart disease mortality is low in France: the time lag explanation.

Authors:  M Law; N Wald
Journal:  BMJ       Date:  1999-05-29

Review 2.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Cholesterol lowering diets and coronary heart disease. Advice should now be to increase intake of vegetable oils and fish.

Authors:  M F Oliver
Journal:  BMJ       Date:  1998-10-31

Review 4.  Antioxidant and antiplatelet activity by polyphenol-rich nutrients: focus on extra virgin olive oil and cocoa.

Authors:  Lorenzo Loffredo; Ludovica Perri; Cristina Nocella; Francesco Violi
Journal:  Br J Clin Pharmacol       Date:  2016-04-01       Impact factor: 4.335

Review 5.  Mediterranean diet and cardiovascular disease: historical perspective and latest evidence.

Authors:  Michel de Lorgeril
Journal:  Curr Atheroscler Rep       Date:  2013-12       Impact factor: 5.113

Review 6.  The Mediterranean diet: rationale and evidence for its benefit.

Authors:  Michel de Lorgeril; Patricia Salen
Journal:  Curr Atheroscler Rep       Date:  2008-12       Impact factor: 5.113

Review 7.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-07-06

8.  The kaiser permanente northwest cardiovascular risk factor management program: a model for all.

Authors:  Jodi S Joyce; Martina M Fetter; Dean H Klopfenstein; Michael K Nash
Journal:  Perm J       Date:  2005

9.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-11-30

Review 10.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.